台股 » 個股 » 中裕 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中裕

(4147)
可現股當沖
  • 股價
    84.9
  • 漲跌
    ▲0.4
  • 漲幅
    +0.47%
  • 成交量
    471
  • 產業
    上櫃 生技醫療類股
  • 318人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
中裕 (4147)籌碼相關-元大-新盛 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-新盛 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/2200.000.384.8484.90-0.31,116-0.02%
2025/01/17184.600.385.3784.600.81,1310.07%
2025/01/1600.00086.2486.5001,1330.00%
2025/01/142.188.2900.0087.302.11,1470.18%
2025/01/130.289.73295.5589.90-1.81,132-0.16%
2025/01/100.589.48289.6090.50-1.61,064-0.15%
2025/01/097.793.71491.1387.503.71,0140.36%
2025/01/088.198.946100.9597.202.18720.24%
2025/01/07092.70192.7092.70-1649-0.15%
2025/01/061.190.30290.4089.80-1611-0.16%
2025/01/03088.3000.0088.3006000.00%
2024/12/270.185.9000.0085.800.15930.01%
2024/12/2600.00285.8586.30-2592-0.34%
2024/12/17181.5000.0082.0016250.16%
2024/12/1300.00183.0083.00-1627-0.16%
2024/12/10388.001.190.3287.501.96150.31%
2024/12/0900.00489.8590.10-4600-0.67%
2024/12/06288.601.188.7787.600.95730.16%
2024/12/0400.00185.3085.30-1529-0.19%
2024/11/29184.3000.0084.3015240.19%
2024/11/27483.3000.0083.6045350.75%
2024/11/26683.9700.0083.9065391.11%
2024/11/2500.001384.9285.00-13543-2.39%
2024/11/2200.00480.3879.90-4512-0.78%
2024/11/2100.00779.9779.70-7511-1.37%
2024/11/2000.00179.9079.00-1515-0.19%
2024/11/19578.2000.0078.6055230.96%
2024/11/18778.7300.0078.7075341.31%
2024/11/11279.901282.2982.40-10533-1.88%
2024/11/08580.2000.0080.1055220.96%
2024/11/0700.00382.3081.60-3525-0.57%
2024/11/06380.9700.0080.8035280.57%
2024/11/04581.6600.0081.6055790.86%
2024/10/2200.00279.0080.60-2562-0.36%
2024/10/09174.6000.0073.9016220.16%
2024/10/01079.7000.0079.4006350.00%
2024/09/2700.000.180.3080.10-0.1649-0.01%
2024/09/1800.00181.4081.40-1665-0.15%
2024/09/1200.00080.0079.8006820.00%
2024/09/0400.00181.5081.30-1742-0.13%
2024/09/02186.3000.0085.3017530.13%
2024/08/30286.8000.0086.4027500.27%
2024/08/2800.00184.0083.70-1733-0.14%
2024/08/220.181.5000.0081.300.17590.01%
2024/08/19179.2000.0079.4017520.13%
2024/08/09177.9000.0078.4017850.13%
2024/08/0700.00575.7075.60-5779-0.64%
2024/08/06574.2000.0070.3057710.65%
2024/08/0200.00183.6082.20-1708-0.14%
2024/07/30182.0000.0083.9017370.14%
2024/07/2200.00189.9087.10-1745-0.13%
2024/07/1700.00188.6088.10-1713-0.14%
2024/07/11085.7000.0084.9007650.01%
2024/07/08187.0000.0086.0018290.12%
2024/07/042.186.9100.0086.902.18890.23%
2024/07/03187.5000.0087.4019530.10%
2024/06/2800.00390.1089.30-31,103-0.27%
2024/06/25187.80287.1587.80-11,121-0.09%
2024/06/24186.801.286.9786.70-0.21,128-0.01%
2024/06/21288.5000.0088.9021,1210.18%
2024/06/19189.8000.0089.5011,1360.09%
2024/06/1100.00193.0091.00-11,182-0.08%
2024/06/070.290.50488.9590.10-3.81,167-0.33%
2024/05/3100.00190.2090.10-11,420-0.07%
2024/05/30189.2000.0088.6011,4750.07%
2024/05/1500.00186.4086.40-12,211-0.05%
2024/05/0700.00186.4086.70-12,336-0.04%
2024/05/0600.00188.0088.00-12,331-0.04%
2024/04/3000.00284.9085.50-22,329-0.09%
2024/04/2900.00184.3086.00-12,338-0.04%
2024/04/2400.00184.6084.80-12,321-0.04%
2024/04/22184.1000.0081.8012,3290.04%
2024/04/19383.1000.0083.1032,3340.13%
2024/04/17189.101888.7487.80-172,356-0.72%
2024/04/16187.003.288.3387.90-2.22,351-0.09%
2024/04/15291.050.192.5090.101.92,3420.08%
2024/04/12194.0000.0094.0012,3390.04%
2024/04/1100.00395.8095.80-32,349-0.13%
2024/04/101.193.7400.0093.201.12,3390.05%
2024/04/09396.43596.2296.20-22,301-0.09%
2024/04/0300.00195.0090.60-12,195-0.05%
2024/04/02188.60489.2088.50-32,088-0.14%
2024/04/01290.3500.0090.1022,0740.10%
2024/03/2600.00189.0088.10-12,033-0.05%
2024/03/2500.000.288.8087.80-0.22,027-0.01%
2024/03/2100.00088.9088.6002,0140.00%
2024/03/1900.000.190.8091.10-0.11,9880.00%
2024/03/18190.4000.0091.3011,9810.05%
2024/03/15692.5200.0090.1061,9700.30%
2024/03/12291.900.193.5091.901.91,9440.10%
2024/03/11194.200.194.2794.100.91,9070.05%
2024/03/08499.0800.0096.8041,8650.21%
2024/03/072105.0000.00107.5021,7970.11%
2024/03/062105.5000.00103.5021,7350.12%
2024/03/053104.509104.00102.50-61,704-0.35%
2024/03/0400.0012.1109.00109.00-12.11,641-0.74%
2024/03/016107.585107.50109.0011,6020.06%
2024/02/295109.202112.50110.5031,5590.19%
2024/02/278.1112.9327.5113.11114.00-19.41,413-1.37%
2024/02/2619.1107.202104.25108.0017.11,2471.37%
2024/02/232105.0000.00102.5021,1070.18%
2024/02/220.196.005.395.7496.30-5.21,019-0.51%
2024/02/21194.5000.0094.8011,0050.10%
2024/02/200.194.70295.0596.30-1.9979-0.20%
2024/02/190.293.501.193.1793.00-0.9952-0.09%
2024/02/16192.50192.9091.6009520.00%
2024/02/1500.00191.1091.10-1963-0.10%
2024/02/05188.7000.0088.7019780.10%
2024/02/02189.6000.0089.8019930.10%
2024/02/01290.34491.4391.50-2985-0.20%
中裕長效型愛滋療法2a臨床全數完成注射 今年底至明年初可獲初步結果Anue鉅亨-2024/08/30
中裕與沙國藥廠簽抗愛滋病新藥中東、北非獨家銷售合約UDN聯合新聞網-2024/03/14
中裕 相關文章